ADVISORY, March 01, 2016 (GLOBE NEWSWIRE) --
Fight Colorectal Cancer, a leading national colorectal cancer nonprofit and Exact Sciences Corp. (Nasdaq:EXAS), a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer will visit the Nasdaq MarketSite in Times Square to celebrate the 4th annual kickoff of their awareness campaign One Million Strong and March Colorectal Cancer Awareness Month.
In honor of the occasion, Lt. Gov. Rebecca Kleefisch of Wisconsin and a colon cancer survivor will ring the Closing Bell along with Fight Coloretcal Cancer President Anjee Davis and Kevin Conroy, chairman and CEO of Exact Sciences.
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Wednesday, March 2, 2016 – 3:45 p.m. to 4:00 p.m. ET
Fight Colorectal Cancer Media Contact:
(703) 548-1225 ext. 442
Exact Sciences Corp. Media Contact:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:
For photos from ceremonies and events visit our Instagram Page:
For news tweets, please visit our Twitter page at:
For exciting viral content and ceremony photos visit our Tumblr Page:
A LiveStream of the Nasdaq Closing Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About Fight Colorectal Cancer
Fight Colorectal Cancer is a leading national colorectal cancer nonprofit based in Washington, D.C. Through patient education, advocacy, and research efforts the group spreads awareness and demands a cure for the second-leading killer in the United States. As the leading advocacy group, the organization serves as a resource for colorectal cancer patients, grassroots advocates, policy makers, medical professionals and health care providers. Learn more at http://www.FightColorectalCancer.org.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Cologuard is included in the colorectal cancer screening guidelines of the American Cancer Society and stool DNA is included in the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, please follow us on Twitter @ExactSciences or find us on Facebook.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.6 trillion and nearly 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.